GEHC

SEC source: 0001465175-25-000006 · wk-form4_1756930424.xml · nonDerivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,493

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001465175-25-000006 · wk-form4_1756930424.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,873

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001323134-25-000005 · wk-form4_1756930278.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,882

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001323134-25-000005 · wk-form4_1756930278.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,354

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001593636-25-000006 · wk-form4_1756930348.xml · nonDerivative · entry 2

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,594

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001593636-25-000006 · wk-form4_1756930348.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,092

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001657919-25-000009 · wk-form4_1756930716.xml · nonDerivative · entry 1

Holton Adam Y · CIK 0001657919 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,768

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001960652-25-000006 · wk-form4_1756930637.xml · nonDerivative · entry 2

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,950

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001960652-25-000006 · wk-form4_1756930637.xml · nonDerivative · entry 1

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,246

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001952159-25-000006 · wk-form4_1756930522.xml · nonDerivative · entry 3

Rott Roland · CIK 0001952159 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,401

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001952159-25-000006 · wk-form4_1756930522.xml · nonDerivative · entry 2

Rott Roland · CIK 0001952159 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,860

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001952159-25-000006 · wk-form4_1756930522.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,550

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001889865-25-000006 · wk-form4_1755605427.xml · nonDerivative · entry 1

Stacherski Kenneth R. · CIK 0001889865 · Chief Enterprise Oper. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,888

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on August 15, 2027, and 50% will vest on August 15, 2028.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001932393-25-000036 · wk-form4_1748981313.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,832

F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-25-028703 · wk-form4_1748642692.xml · nonDerivative · entry 1

LAVIZZO-MOUREY RISA J · CIK 0001034465 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,157

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028691 · wk-form4_1748642008.xml · nonDerivative · entry 2

Madden Anne T · CIK 0001684059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,611

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

SEC source: 0001628280-25-028691 · wk-form4_1748642008.xml · nonDerivative · entry 1

Madden Anne T · CIK 0001684059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,855

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028686 · wk-form4_1748641539.xml · nonDerivative · entry 2

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,611

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

SEC source: 0001628280-25-028686 · wk-form4_1748641539.xml · nonDerivative · entry 1

Hochman Rodney F · CIK 0001468966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,855

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028679 · wk-form4_1748641028.xml · nonDerivative · entry 2

Stromberg William J · CIK 0001352578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,330

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

SEC source: 0001628280-25-028679 · wk-form4_1748641028.xml · nonDerivative · entry 1

Stromberg William J · CIK 0001352578 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,293

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028669 · wk-form4_1748640327.xml · nonDerivative · entry 2

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,790

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F4 · shares: Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.

SEC source: 0001628280-25-028669 · wk-form4_1748640327.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,207

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").

F2 · shares: Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: Reflects the transfer by the reporting person of 289,906 shares of GE HealthCare common stock to a family trust on September 23, 2024.

SEC source: 0001628280-25-028698 · wk-form4_1748642383.xml · nonDerivative · entry 1

LESJAK CATHERINE A · CIK 0001256992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,116

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028696 · wk-form4_1748642213.xml · nonDerivative · entry 1

HOWELL LLOYD JR · CIK 0001505488 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,116

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028688 · wk-form4_1748641790.xml · nonDerivative · entry 1

Mihaljevic Tomislav · CIK 0001917584 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,116

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-25-028683 · wk-form4_1748641313.xml · nonDerivative · entry 1

Yang Watkin Phoebe L. · CIK 0001940538 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,116

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001920839-25-000007 · wk-form4_1747686466.xml · derivative · entry 3

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,754

Underlying: Common Stock, par value $0.01 per share · 18,754 shares

Expires 2035-05-15

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2026, 33% will become exercisable on September 1, 2027, and 34% will become exercisable on September 1, 2028.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2026, 33% will become exercisable on September 1, 2027, and 34% will become exercisable on September 1, 2028.

SEC source: 0001920839-25-000007 · wk-form4_1747686466.xml · nonDerivative · entry 2

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,031

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2026, 33% will vest on September 1, 2027, and 34% will vest on September 1, 2028.

SEC source: 0001920839-25-000007 · wk-form4_1747686466.xml · nonDerivative · entry 1

Bankes Jeannette · CIK 0001920839 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,174

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on May 15, 2026, and 50% will vest on May 15, 2027.

SEC source: 0001628280-25-010702 · wk-form4_1741221653.xml · derivative · entry 2

Rackliffe Philip · CIK 0002027284 · CEO, AVS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,058

Underlying: Common Stock, par value $0.01 per share · 14,058 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010702 · wk-form4_1741221653.xml · nonDerivative · entry 1

Rackliffe Philip · CIK 0002027284 · CEO, AVS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,473

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010704 · wk-form4_1741221756.xml · derivative · entry 2

Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,472

Underlying: Common Stock, par value $0.01 per share · 14,472 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010704 · wk-form4_1741221756.xml · nonDerivative · entry 1

Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,671

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010696 · wk-form4_1741221307.xml · derivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,944

Underlying: Common Stock, par value $0.01 per share · 28,944 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010696 · wk-form4_1741221307.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,572

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010692 · wk-form4_1741221203.xml · derivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,913

Underlying: Common Stock, par value $0.01 per share · 119,913 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010692 · wk-form4_1741221203.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,228

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010700 · wk-form4_1741221515.xml · derivative · entry 2

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,252

Underlying: Common Stock, par value $0.01 per share · 32,252 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010700 · wk-form4_1741221515.xml · nonDerivative · entry 1

SACCARO JAMES · CIK 0001593636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,544

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010689 · wk-form4_1741221114.xml · derivative · entry 2

Holton Adam Y · CIK 0001657919 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,404

Underlying: Common Stock, par value $0.01 per share · 12,404 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010689 · wk-form4_1741221114.xml · nonDerivative · entry 1

Holton Adam Y · CIK 0001657919 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,232

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010711 · wk-form4_1741222071.xml · derivative · entry 4

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,307

Underlying: Common Stock, par value $0.01 per share · 3,307 shares

Expires 2035-03-03

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010711 · wk-form4_1741222071.xml · nonDerivative · entry 2

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,705

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010709 · wk-form4_1741221969.xml · derivative · entry 3

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,096

Underlying: Common Stock, par value $0.01 per share · 9,096 shares

Expires 2035-03-03

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010709 · wk-form4_1741221969.xml · nonDerivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,501

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010707 · wk-form4_1741221839.xml · derivative · entry 4

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,231

Underlying: Common Stock, par value $0.01 per share · 13,231 shares

Expires 2035-03-03

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010707 · wk-form4_1741221839.xml · nonDerivative · entry 2

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,980

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.

SEC source: 0001628280-25-010698 · wk-form4_1741221394.xml · derivative · entry 2

Rott Roland · CIK 0001952159 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,742

Underlying: Common Stock, par value $0.01 per share · 22,742 shares

Expires 2035-03-03

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.

SEC source: 0001628280-25-010698 · wk-form4_1741221394.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,235

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.